Proficio Capital Partners LLC purchased a new stake in shares of American Vanguard Co. (NYSE:AVD – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 20,326 shares of the basic materials company’s stock, valued at approximately $94,000. Proficio Capital Partners LLC owned 0.07% of American Vanguard as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Ieq Capital LLC purchased a new stake in shares of American Vanguard in the fourth quarter worth $54,000. JPMorgan Chase & Co. boosted its holdings in American Vanguard by 20.2% in the 3rd quarter. JPMorgan Chase & Co. now owns 298,898 shares of the basic materials company’s stock worth $1,584,000 after buying an additional 50,230 shares during the period. Barclays PLC increased its stake in American Vanguard by 59.3% in the 3rd quarter. Barclays PLC now owns 73,112 shares of the basic materials company’s stock worth $388,000 after buying an additional 27,229 shares in the last quarter. XTX Topco Ltd purchased a new stake in American Vanguard in the 3rd quarter worth $104,000. Finally, Quantinno Capital Management LP bought a new stake in American Vanguard during the third quarter valued at about $89,000. Hedge funds and other institutional investors own 79.04% of the company’s stock.
Wall Street Analyst Weigh In
Separately, Lake Street Capital set a $14.00 price objective on American Vanguard in a research note on Tuesday, January 21st.
American Vanguard Price Performance
AVD stock opened at $4.71 on Friday. The company has a debt-to-equity ratio of 0.55, a quick ratio of 0.79 and a current ratio of 1.89. The company’s fifty day moving average price is $5.24 and its 200-day moving average price is $5.41. American Vanguard Co. has a one year low of $4.26 and a one year high of $14.28. The company has a market capitalization of $135.45 million, a PE ratio of -4.57 and a beta of 0.91.
American Vanguard Company Profile
American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. It manufactures and formulates chemicals, including insecticides, fungicides, herbicides, soil health, plant nutrition, molluscicides, growth regulators, soil fumigants, and biorationals in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection.
See Also
- Five stocks we like better than American Vanguard
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- 3 Undervalued Stocks You Can Buy at a Discount Now
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- AMD Stock: Can the PC Refresh Cycle Spark a Rally?
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Micron Stock Spikes 7%—3 Key Catalysts Behind the Move
Receive News & Ratings for American Vanguard Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Vanguard and related companies with MarketBeat.com's FREE daily email newsletter.